Bowel preparation in the Endoscopy Unit of Hospital Universitario Hernando Moncaleano Perdomo, one year experience: case series
Abstract
Appropriate colonic preparation is essential for early detection of colonic neoplastic lesions. Objective: To describe the clinical response of the two colonic preparations currently used in the digestive endoscopy service of the Hospital Universitario Hernando Moncaleano Perdomo at Neiva, Colombia in outpatients. Methods: A descriptive study carried out in a case series, by reviewing clinical records of patients who underwent ambulatory colonoscopy at the endoscopic unit of the hospital. Data were collected from September 3, 2014 to 3 of September 2015. Half patients received standard dose of polyethylene glycol (group 1) and the other received polyethylene glycol + bisacodyl (group 2). We collected sociodemographic variables, preparation colonic scale of the Boston University (Boston Scale), adverse reactions and colonoscopic findings. Results: A high proportion of patients have good colonic preparation according Boston Scale with both schemes without statistically significant differences between groups. An important proportion of adverse reactions were found. Conclusion: Both the preparation of half of Polyethylene Glycol plus Bisacodyl 20mg and the standard Polyethylene Glycol had an excellent performance in the preparation of the colon of outpatients.Downloads
References
(1) Harewood GC, Sharma VK, de Garmo P. Impact of colonoscopy preparation quality on detection of suspected colonic neoplasia. Gastrointest Endosc 2003; 58(1):76–9.
(2) Lawrence B. Cohen. Advances in Bowel Preparation for Colonoscopy. Gastrointest Endosc 2015; 25(1):184–186.
(3) Johnson DA, Barkun AN, Cohen LB, et al. Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the U.S. Multi-Society Task Force on Colorectal.
(4) Wu KL, Rayner CK, Chuah SK, Chiu KW, Lu CC, Chiu YC. Impact of low-residue diet on bowel preparation for colonoscopy. Dis Colon Rectum 2011;54(1):107-12.
(5) Enestvedt BK, Fennerty MB, Eisen GM. Randomised clinical trial: MiraLAX vs. golytely - a controlled study of efficacy and patient tolerability in bowel preparation for colonoscopy. Aliment Pharmacol Ther 2011;33:33-40.
(6) Paola Cesaro, et al. A new low-volume isosmotic polyethylene glycol solution plus bisacodyl versus split-dose 4 L polyethylene glycol for bowel cleansing prior to colonoscopy: A randomised controlled trial, Digestive and Liver Disease, Volume 45, Issue 1, January 2013, Pages 23-27
(7) Lawrence B. Cohen, Advances in Bowel Preparation for Colonoscopy, Gastrointestinal Endoscopy Clinics of North America, Volume 25, Issue 2, April 2015, Pages 190.
(8) Parmar R, Martel M, Rostom A, Barkun AN. Validated Scales for Colon Cleansing: A Systematic Review. Am J Gastroenterol. 2016; 111(2): 197–205.
(9) Audrey H. Calderwood, Brian C. Jacobson, Comprehensive validation of the Boston Bowel Preparation Scale, Gastrointestinal Endoscopy, Volume 72, Issue 4, October 2010, Page 689.
(10) Audrey H. Calderwood, Paul C. Schroy III, David A. Lieberman, Judith R. Logan, Michael Zurfluh, Brian C. Jacobson, Boston Bowel Preparation Scale scores provide a standardized definition of adequate for describing bowel cleanliness, Gastrointestinal Endoscopy, Volume 80, Issue 2, August 2014, Page 272.
(11) ONU. Declaración Universal de los Derechos Humanos [Monografia en Internet]. E.U.A: ONU, 2012 [consultado, diciembre 2015]. Disponible en http:// www.un.org/es/documents/udhr/.
(12) Observatorio de Bioetica i Dret Parc Cientific de Barcelona. Codigo de Nüremberg [monografia en internet]. España: UB,2012 [consultado, diciembre 2015]. Disponible en http:// www.pc.ub.edu/bioeticaidrest/archivos/norm/CodigoNuremberg.pdf.
(13) Asamblea Medica Mundial. Declaracion de Helsinski [monografía en internet].. Mexico: UNAM,2012 [consultado, diciembre 2015]. Disponible en
http://www.inb.unam.mx/bioética/documentos/declaración_helsinski.pdf.
(14) Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Francia: WHO, International Agency for Research on Cancer; 2013. [consultado, diciembre 2015]. Disponible en: http://globocan.iarc.fr.
(15) Ness RM, Manam R, Hoen H and Chalasani N. Predictors of inadequate bowel preparation for colonoscopy. American Journal of Gastroenterology 2001;96:1797–802.
(16) Pontone S. Low-volume plus ascorbic acid vs high-volume plus simethicone bowel preparation before colonoscopy. World J Gastroenterol 2011; 17: 4689 – 4695.
(17) Corporaal S, Kleibeuker JH, Koornstra JJ, Low-volume PEG plus ascorbic acid versus high-volume PEG as bowel preparation for colonoscopy. Scand J Gastroenterol 2010; 45: 1380 – 1386.
(18) Lieberman DA, Holub JL, Moravec MD, Eisen GM, Peters D, Morris CD. Prevalence of Colon Polyps Detected by Colonoscopy Screening in Asymptomatic Black and White Patients. JAMA. 2008;300(12):1417-1422.
(19) Giacosa A, Frascio F, Munizzi F. Epidemiology of colorectal polyps. Tech Coloproctol 2004;8:s243-7.
(20) Golub RW, Kerner BA, Wise WE Jr. Colonoscopic preparations-whichone? A blinded, prospective, randomized trial. Dis Colon Rectum 1995;58:594-7.
(21) Marshall JB, Pineda JJ, Barthel JS, et al. Prospective, randomized trial comparing sodium phosphate solution with polyethylene glycol electrolyte lavage for colonoscopy preparation. Gastrointest Endosc 1993;39:631-4.
Copyright (c) 2020 Universidad del Cauca
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
.png)
